Rituximab not beneficial long-term in Sjorgen’s Syndrome
Image: PD 1. The results of this study suggest that rituximab (Rituxin) treatment is not associated with a significant improvement ...
Tag: Rituxan
Rituximab noninferior to conventional therapy in ANCA-associated vasculitis: RAVE Trial
Image: PD/Rituximab (Rituxan, MabThera) 1. At 18 months, patients with ANCA-associated vasculitis treated with one course of rituximab had similar ...
